tiprankstipranks
ILEX Medical Ltd. (IL:ILX)
TASE:ILX
Israel Market
ILX
Ilex Medical
RESEARCH TOOLSreports

Ilex Medical (ILX) Ratios

0 Followers

Ilex Medical Ratios

IL:ILX's free cash flow for Q4 2025 was ₪0.23. For the 2025 fiscal year, IL:ILX's free cash flow was decreased by ₪ and operating cash flow was ₪0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.83 2.83 2.68 2.46 2.81
Quick Ratio
 2.07 2.07 2.09 1.89 2.17
Cash Ratio
 0.69 0.69 0.66 0.53 0.89
Solvency Ratio
 0.34 0.34 0.25 0.25 0.53
Operating Cash Flow Ratio
 0.29 0.29 0.30 0.29 0.31
Short-Term Operating Cash Flow Coverage
 0.00 0.00 262.48 194.28 124.76
Net Current Asset Value
₪ 415.64M₪ 415.64M₪ 370.89M₪ 293.40M₪ 348.75M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.05 0.05 0.06
Debt-to-Equity Ratio
 0.07 0.07 0.08 0.08 0.08
Debt-to-Capital Ratio
 0.06 0.06 0.07 0.07 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 <0.01
Financial Leverage Ratio
 1.45 1.45 1.54 1.63 1.47
Debt Service Coverage Ratio
 48.86 48.86 35.57 34.25 70.99
Interest Coverage Ratio
 25.49 25.49 27.55 30.89 98.39
Debt to Market Cap
 0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 4.35 4.35 4.81 4.55 4.71
Net Debt to EBITDA
 -1.03 -1.03 -1.11 -0.81 -0.79
Profitability Margins
Gross Profit Margin
22.76%22.76%23.50%24.91%32.67%
EBIT Margin
8.20%8.20%6.96%8.15%15.86%
EBITDA Margin
13.52%13.52%12.29%13.28%21.59%
Operating Profit Margin
6.01%6.01%7.25%8.81%18.12%
Pretax Profit Margin
7.96%7.96%6.69%7.46%15.67%
Net Profit Margin
5.97%5.97%4.24%5.47%11.70%
Continuous Operations Profit Margin
5.97%5.97%4.97%5.47%11.70%
Net Income Per EBT
74.94%74.94%63.28%73.32%74.68%
EBT Per EBIT
132.51%132.51%92.33%84.61%86.48%
Return on Assets (ROA)
5.60%5.60%3.92%5.01%11.36%
Return on Equity (ROE)
8.34%8.11%6.03%8.16%16.66%
Return on Capital Employed (ROCE)
7.59%7.59%9.19%11.12%23.48%
Return on Invested Capital (ROIC)
5.58%5.58%6.70%8.03%17.21%
Return on Tangible Assets
5.71%5.71%4.02%5.15%11.78%
Earnings Yield
8.24%7.43%4.67%7.73%9.24%
Efficiency Ratios
Receivables Turnover
 3.50 3.50 3.68 3.24 3.51
Payables Turnover
 5.11 5.11 5.85 4.06 4.13
Inventory Turnover
 3.70 3.70 4.46 4.38 4.03
Fixed Asset Turnover
 6.32 6.32 5.92 5.79 6.01
Asset Turnover
 0.94 0.94 0.93 0.92 0.97
Working Capital Turnover Ratio
 2.04 2.03 2.15 2.28 2.18
Cash Conversion Cycle
 131.52 131.52 118.64 106.32 106.02
Days of Sales Outstanding
 104.40 104.40 99.23 112.81 103.85
Days of Inventory Outstanding
 98.60 98.60 81.85 83.38 90.59
Days of Payables Outstanding
 71.48 71.48 62.44 89.87 88.43
Operating Cycle
 203.00 203.00 181.08 196.19 194.45
Cash Flow Ratios
Operating Cash Flow Per Share
 6.50 6.50 7.31 7.19 6.18
Free Cash Flow Per Share
 3.82 3.82 4.32 2.53 3.67
CapEx Per Share
 2.68 2.68 2.98 4.66 2.51
Free Cash Flow to Operating Cash Flow
 0.59 0.59 0.59 0.35 0.59
Dividend Paid and CapEx Coverage Ratio
 1.67 1.67 1.68 1.09 0.79
Capital Expenditure Coverage Ratio
 2.42 2.42 2.45 1.54 2.46
Operating Cash Flow Coverage Ratio
 1.56 1.56 1.59 1.67 1.35
Operating Cash Flow to Sales Ratio
 0.08 0.08 0.09 0.09 0.08
Free Cash Flow Yield
6.36%5.73%5.79%4.30%3.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.14 13.45 21.40 12.93 10.82
Price-to-Sales (P/S) Ratio
 0.72 0.80 0.91 0.71 1.27
Price-to-Book (P/B) Ratio
 0.98 1.09 1.29 1.06 1.80
Price-to-Free Cash Flow (P/FCF) Ratio
 15.72 17.46 17.27 23.28 26.71
Price-to-Operating Cash Flow Ratio
 9.25 10.26 10.22 8.18 15.85
Price-to-Earnings Growth (PEG) Ratio
 0.45 0.32 -0.92 -0.26 -0.22
Price-to-Fair Value
 0.98 1.09 1.29 1.06 1.80
Enterprise Value Multiple
 4.32 4.91 6.26 4.51 5.07
Enterprise Value
 543.75M 618.41M 708.32M 557.85M 955.94M
EV to EBITDA
 4.32 4.91 6.26 4.51 5.07
EV to Sales
 0.58 0.66 0.77 0.60 1.10
EV to Free Cash Flow
 12.70 14.45 14.67 19.74 23.10
EV to Operating Cash Flow
 7.46 8.49 8.68 6.94 13.71
Tangible Book Value Per Share
 59.38 59.38 55.72 53.20 51.51
Shareholders’ Equity Per Share
 61.07 61.07 57.87 55.72 54.36
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.26 0.27 0.25
Revenue Per Share
 83.02 83.02 82.39 83.19 77.36
Net Income Per Share
 4.95 4.95 3.49 4.55 9.05
Tax Burden
 0.75 0.75 0.63 0.73 0.75
Interest Burden
 0.97 0.97 0.96 0.91 0.99
Research & Development to Revenue
 <0.01 <0.01 <0.01 0.01 0.01
SG&A to Revenue
 0.02 0.02 0.02 <0.01 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.98 0.98 1.49 1.16 0.51
Currency in ILS